Table 1. Demographic and spirometric data of the study participants.a.
| Variables | Groups | ||
|---|---|---|---|
| Control | Smoker | COPD | |
| (n = 9) | (n = 12) | (n = 36) | |
| Age, years | 47.22 ± 1.41 | 50.30 ± 4.94 | 62.75 ± 9.98 |
| Male/Female, n/n | 4/5 | 3/9 | 24/12 |
| FVC, L | 3.37 ± 1.20 | 3.38 ± 0.61 | 2.90 ± 0.95 |
| FVC, % of predicted | 100.88 ± 12.17 | 103.30 ± 12.10 | 86.08 ± 20.23 |
| FEV1, L | 2.98 ± 0.72 | 2.78 ± 0.54 | 1.59 ± 0.69 |
| FEV1,% of predicted | 99.31 ± 11.02 | 104 ± 9.87 | 59.84 ± 21.30 |
| FEV1/FVC, % | 79.67 ± 5.19 | 83.90 ± 9.68 | 53.07 ± 10.54 |
| Comorbiditiesb | |||
| SAH | 1 | 3 | 9 |
| Hypothyroidism | 2 | 1 | |
| Dyslipidemia | 1 | ||
| Glaucoma | 1 | ||
| Bipolar disorder | 1 | ||
| Calcinosis | 1 | ||
SAH
: systemic arterial hypertension
a
Values expressed as mean ± SD, except where otherwise indicated
b
Values expressed as n of patients.